v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash $ 6,640,468 $ 3,325,131
Advances on research and development contract services 208,972 258,059
Prepaid insurance 142,776 268,179
Prepaid expenses 10,000 10,000
Total current assets 7,002,216 3,861,369
Total assets 7,002,216 3,861,369
Current Liabilities    
Accounts payable and accrued expenses 403,729 373,042
Warrant liability 2,413 4,670
Total current liabilities 406,142 377,712
Total liabilities 406,142 377,712
Commitments and Contingencies
Stockholders’ Equity    
Preferred Stock, $0.001 par value per share; 20,000,000 shares authorized; none issued or outstanding at June 30, 2025 and December 31, 2024
Common stock, $0.001 par value per share; 100,000,000 shares authorized; 1,685,260 and 492,417 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively [1] 1,685 492
Additional paid-in capital [1] 93,373,378 88,504,543
Accumulated deficit (86,778,989) (85,021,378)
Total stockholders’ equity 6,596,074 3,483,657
Total liabilities and stockholders’ equity $ 7,002,216 $ 3,861,369
[1] Adjusted to reflect the reverse stock split as described in Note 1.